Report overview
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
These days, many manufacturers provide multi-modal systems combining the advantages of anatomical modalities such as CT and MR with the functional imaging of PET and SPECT. As in the clinical market, common combinations are SPECT/CT, PET/CT and PET/MR.
This report aims to provide a comprehensive presentation of the global market for Pre-Clinical Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Clinical Imaging System. This report contains market size and forecasts of Pre-Clinical Imaging System in global, including the following market information:
Global Pre-Clinical Imaging System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pre-Clinical Imaging System Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pre-Clinical Imaging System companies in 2022 (%)
The global Pre-Clinical Imaging System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Standalone Imaging System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pre-Clinical Imaging System include Bioscan, Bruker, PerkinElmer, Siemens Healthcare GmbH, Aspect Imaging, Thermo Fisher Scientific, MR Solutions, LI-COR and TriFoil Imaging, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pre-Clinical Imaging System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pre-Clinical Imaging System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pre-Clinical Imaging System Market Segment Percentages, by Type, 2022 (%)
Standalone Imaging System
Multimodal Imaging System
Global Pre-Clinical Imaging System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pre-Clinical Imaging System Market Segment Percentages, by Application, 2022 (%)
Clinical Research Organization (CRO)
Pharmaceutical Industries
Biotechnology Industries
Government and Private Research Institutes
Global Pre-Clinical Imaging System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pre-Clinical Imaging System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pre-Clinical Imaging System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pre-Clinical Imaging System revenues share in global market, 2022 (%)
Key companies Pre-Clinical Imaging System sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pre-Clinical Imaging System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bioscan
Bruker
PerkinElmer
Siemens Healthcare GmbH
Aspect Imaging
Thermo Fisher Scientific
MR Solutions
LI-COR
TriFoil Imaging
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pre-Clinical Imaging System, market overview.
Chapter 2: Global Pre-Clinical Imaging System market size in revenue and volume.
Chapter 3: Detailed analysis of Pre-Clinical Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pre-Clinical Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pre-Clinical Imaging System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
